Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations and Condensed Statements of Operations (Unaudited)

v3.7.0.1
Condensed Consolidated Statements of Operations and Condensed Statements of Operations (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Apr. 30, 2017
Apr. 30, 2016
Apr. 30, 2017
Apr. 30, 2016
Income Statement [Abstract]        
Revenue
Expenses:        
Research and development 2,656,073 3,376,757 8,638,423 11,149,652
General and administrative 1,904,899 2,874,362 6,912,053 9,174,406
Loss before income taxes (4,560,972) (6,251,119) (15,550,476) (20,324,058)
Provision for income taxes 290 1,391 2,462
Net loss $ (4,560,972) $ (6,251,409) $ (15,551,867) $ (20,326,520)
Basic and diluted net loss per common share $ (0.22) $ (0.37) $ (0.79) $ (1.27)
Weighted average shares used in computing basic and diluted net loss per common share 20,704,393 16,971,214 19,809,739 15,955,116